ProCE Banner Activity

MedicalMinute: Updates on Emerging Oral Therapies for IBD

Slideset Download
Review safety and efficacy data on new and emerging oral therapies for IBD, including S1PR modulators and JAK-STAT inhibitors.

Released: August 24, 2021

Expiration: August 23, 2022

No longer available for credit.

Share

Faculty

Millie D. Long

Millie D. Long, MD, MPH, FACG, AGAF

Professor of Medicine
Director,
Gastroenterology and Hepatology Fellowship Program
Vice-Chief for Education
Division of Gastroenterology and Hepatology
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AbbVie

Bristol Myers Squibb

Faculty Disclosure

Primary Author

Millie D. Long, MD, MPH, FACG, AGAF

Professor of Medicine
Director,
Gastroenterology and Hepatology Fellowship Program
Vice-Chief for Education
Division of Gastroenterology and Hepatology
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina